2011
DOI: 10.1016/j.jpain.2011.01.001
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological Management of Persistent Pain in Older Persons

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
13
0
2

Year Published

2012
2012
2021
2021

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(16 citation statements)
references
References 54 publications
1
13
0
2
Order By: Relevance
“…Los analgésicos coadyuvantes son fármacos que se desarrollaron para otra indicación, pero que han demostrado ser útiles en el tratamiento del dolor persistente y refractario, especialmente neuropático (Tabla II) (30).…”
Section: Analgésicos Adyuvantesunclassified
See 1 more Smart Citation
“…Los analgésicos coadyuvantes son fármacos que se desarrollaron para otra indicación, pero que han demostrado ser útiles en el tratamiento del dolor persistente y refractario, especialmente neuropático (Tabla II) (30).…”
Section: Analgésicos Adyuvantesunclassified
“…El manejo del dolor en el anciano precisa de un conocimiento específico de los fármacos, de sus características farmacocinéticas y farmacodinámicas y de la relaciones entre éstas y el tipo de paciente anciano, con características diferentes en el paciente frágil. Al objetivo de aliviar el dolor, se debe sumar el de evitar yatrogenia (Tabla III) (30). Gastrointestinal Renal Cardiovascular SNC…”
Section: Conclusionesunclassified
“…Common ADRs, primarily dizziness, somnolence, edema, and gait disturbances, were reported in 66% of patients, but the ADRs were mostly tolerable, and the rate of serious ADEs was similar to placebo [140]. Pregabalin and gabapentin do not affect major CYP enzymes, which makes them less likely to have drug‐drug interactions [141]. Gabapentin levels can be increased by naproxen or morphine, and its absorption can be impaired by aluminum‐magnesium antacids [141].…”
Section: Commonly Administered Potentially Problematic Medicationsmentioning
confidence: 99%
“…Pregabalin and gabapentin do not affect major CYP enzymes, which makes them less likely to have drug‐drug interactions [141]. Gabapentin levels can be increased by naproxen or morphine, and its absorption can be impaired by aluminum‐magnesium antacids [141]. Consensus recommendations have established renal dosing for gabapentin in patients with chronic renal insufficiency: a maximum daily dose of 1200 mg for creatinine clearance (CrCl) 30‐59 mL/min, 600 mg for CrCl 15‐29 mL/min, and 300 mg for CrCl <15 mL/min or for patients on hemodialysis [142] (Table 2).…”
Section: Commonly Administered Potentially Problematic Medicationsmentioning
confidence: 99%
“…Pain is a common complaint among the aging population, particularly among the older residents of nursing homes (1)(2)(3); it is mostly due to the increasing prevalence of age-related disorders, such as arthritis, osteoporosis, and peripheral vascular diseases (4), which are mostly progressive. Usually the resultant pain is persisting due to the degenerative nature of these conditions.…”
Section: Introductionmentioning
confidence: 99%